Lipid-lowering treatment has been regarded as a potential strategy to halt advancement of #diabetic retinopathy. In the latest study, peroxisome proliferator-activated receptor gamma (#PPARG) showed that activation lowers risk of background DR (OR=0.12) & PDR (OR=0.25)—likely via glucose control. There was no significant causal relationship between lipid traits and risk of full-course DR: https://bit.ly/43OWBeS #Diabetes #Ophthalmology #Retinopathy #Retina #Vision
